Improvement in overall and cancer-specific survival in contemporary, metastatic prostate cancer chemotherapy exposed patients.
Benedikt HoehChristoph WürnschimmelRocco S FlammiaBenedikt HorlemannGabriele SorceFrancesco ChierigoZhe TianFred SaadMarkus GraefenMichele GallucciAlberto BrigantiCarlo TerroneShahrokh F ShariatDerya TilkiLuis A KluthPhilipp MandelFelix K H ChunPierre I KarakiewiczPublished in: The Prostate (2021)
In mPCa patients, chemotherapy rates increased over time. A concomitant increase in survival was also recorded.